One out of every eight cancers diagnosed around the world last year trace back to an infection, not bad luck or genetics alone.
Quick Take
- A new study from the International Agency for Research on Cancer (IARC) ties about 2.3 million new cancer cases in 2024 to infections, roughly 12% of the global total.
- Five pathogens account for most of the burden: Helicobacter pylori bacteria, HPV, hepatitis B, Epstein-Barr virus, and hepatitis C.
- The analysis covers 12 infectious agents total, including HIV and Merkel cell polyomavirus, plus newly confirmed links like Epstein-Barr virus and stomach cancer.
- IARC points to vaccines, screening, and early treatment as proven ways to cut this burden.
What The New Global Study Found
The IARC, part of the World Health Organization, published its findings in The Lancet Oncology. Researchers used data from the agency’s Global Cancer Observatory to estimate how many 2024 cancer cases came from infections. The answer: about 2.3 million cases, or 12% of all new cancers diagnosed worldwide that year.
The study did not look at every germ that exists. It focused on 12 specific infectious agents already classified as proven causes of cancer in humans. That list includes viruses, one bacterium, and parasites, each tied to specific tumor types through decades of research.
Five Culprits Drive Most Of The Burden
One bacterium stands out above the rest. Helicobacter pylori, which lives in the stomach lining and causes ulcers, is linked to about 760,000 cancer cases, making it the single biggest infectious driver of cancer worldwide. HPV follows close behind at roughly 750,000 cases, mostly cervical cancer.
Hepatitis B virus accounts for about 360,000 cases, largely liver cancer. Epstein-Barr virus, best known for causing mono, is tied to roughly 260,000 cases. Hepatitis C adds another 160,000. Together, these five pathogens make up the overwhelming majority of the infection-linked cancer total.
New Links Expand The Picture
This study goes beyond the usual suspects. Researchers added HIV and Merkel cell polyomavirus to the list of agents tracked, along with newly confirmed cancer connections. One notable addition: fresh evidence tying Epstein-Barr virus to stomach cancer, a link that wasn’t firmly established in earlier IARC reports.
That expansion matters because it reflects how fast the science keeps moving. Pathogens once thought to only cause mild illness are now understood to raise cancer risk years or decades after infection. Tracking these slow-building threats requires constant updates to global cancer data.
How This Compares To Past Estimates
This isn’t the first time IARC has run these numbers, and the trend line is remarkably steady. A similar analysis for 2018 found 2.2 million infection-attributable cases, or 13% of the global total. A separate estimate for 2020 put the figure at 2.3 million cases, close to 12%. The 2024 numbers land squarely in that same range, suggesting the overall share of cancer linked to infections has held fairly constant even as detection and classification methods improve.
Prevention Tools Already Exist
The encouraging part of this story is that many of these cancers are preventable with tools already on the shelf. IARC highlights HPV vaccination, cervical cancer screening, hepatitis B vaccination, and routine testing and treatment for H. pylori infection as proven interventions that lower risk.
None of these tools are experimental. HPV vaccines have been available for nearly two decades. Hepatitis B shots are standard in many childhood immunization schedules. H. pylori can be detected with a simple breath or stool test and cleared with antibiotics. The barrier isn’t science, it’s access and follow-through.
Why Access Gaps Still Matter
Vaccination rates, screening availability, and treatment access vary enormously by country and region. Places with weaker health infrastructure tend to have less access to HPV shots, cervical screening, and hepatitis B vaccines, even though these same places often carry a heavier cancer burden from these infections. Closing that gap is where public health officials say the biggest prevention gains are waiting to be made.
For American readers, the takeaway is practical rather than alarming. Infections causing cancer isn’t new science fiction, it’s an established, well-documented reality backed by two decades of consistent global data. Vaccines and screening tests that already exist in doctors’ offices across the country remain the clearest, most proven path to lowering that 12% figure over time.
🦠Did you know that around one in eight cancers is linked to infections?
Understanding infection-related cancer risks highlights the importance of prevention, vaccination and early detection.
🔗 https://t.co/7G5lqU6mrr#CancerPrevention #PublicHealth #PersonalisedMedicine pic.twitter.com/6yPUaQ2IJO
— International Alliance for Personalised Medicine (@united4cancer) October 12, 2026
Families weighing vaccine decisions or screening schedules now have a clearer global picture to draw on. The data doesn’t change what doctors have recommended for years, it reinforces it with fresh, worldwide numbers.
Sources:
time.com, iarc.who.int, gco.iarc.who.int
